cellular therapies Syndicate content

Feb 20, 2018

BALTIMORE & MEMPHIS, Tenn.--(BUSINESS WIRE)--Cognate BioServices, a leading contract development and manufacturing organization (“CDMO”) in the global cellular therapies industry, announced today it has completed a management buyout (“MBO”) and raised capital from a group of global investment firms including...